Cargando…

Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations

Dissolving polymeric microneedle arrays formulated to contain recombinant CN54 HIVgp140 and the TLR4 agonist adjuvant MPLA were assessed for their ability to elicit antigen-specific immunity. Using this novel microneedle system we successfully primed antigen-specific responses that were further boos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pattani, Aditya, McKay, Paul F., Garland, Martin J., Curran, Rhonda M., Migalska, Katarzyna, Cassidy, Corona M., Malcolm, R. Karl, Shattock, Robin J., McCarthy, Helen O., Donnelly, Ryan F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science Publishers 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778941/ https://www.ncbi.nlm.nih.gov/pubmed/22960496 http://dx.doi.org/10.1016/j.jconrel.2012.07.039

Ejemplares similares

Optimising CN54gp140 plasmid delivery by comparing intramuscular and intradermal vaccination combinations with and without electroporation
por: Mann, JF, et al.
Publicado: (2012)

Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responses
por: Curran, Rhonda M., et al.
Publicado: (2009)

Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms
por: Donnelly, Louise, et al.
Publicado: (2011)

P11-12. A novel vaginal ring device for the sustained delivery of recombinant C-clade HIV-1 CN54gp140
por: Morrow, RJ, et al.
Publicado: (2009)

CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization
por: Katinger, D, et al.
Publicado: (2012)

P11-11. Stable lyophilised gel vehicles for vaginal administration of recombinant C-clade HIV-1 trimeric CN54gp140
por: Donnelly, L, et al.
Publicado: (2009)

Antigen-specific T lymphocyte responses elicited by a DNA – MVA HIV CN54gp140 immunization regime are significantly altered by the TLR4 adjuvant GLA
por: McKay, PF, et al.
Publicado: (2012)

Antibody responses after intravaginal immunisation with trimeric HIV-1(CN54) clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation
por: Cranage, Martin P., et al.
Publicado: (2011)

P19-54 LB. Interrogating the membrane-proximal external region (MPER) of HIV-1 gp140
por: Jeffs, S, et al.
Publicado: (2009)

A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens
por: Kratochvil, Sven, et al.
Publicado: (2017)

Dissolving Microneedles for Intradermal Vaccination against Shigellosis
por: Pastor, Yadira, et al.
Publicado: (2019)

Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial
por: Gombe, Ben, et al.
Publicado: (2022)

Deferasirox Nanosuspension Loaded Dissolving Microneedles for Intradermal Delivery
por: Faizi, Hafsa Shahid, et al.
Publicado: (2022)

Nanosuspension-Based Dissolving Microneedle Arrays for Intradermal Delivery of Curcumin
por: Abdelghany, Sharif, et al.
Publicado: (2019)

Microneedle-mediated transdermal bacteriophage delivery
por: Ryan, Elizabeth, et al.
Publicado: (2012)

Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination
por: Kratochvil, Sven, et al.
Publicado: (2017)

Mucosal Application of gp140 Encoding DNA Polyplexes to Different Tissues Results in Altered Immunological Outcomes in Mice
por: Mann, Jamie F. S., et al.
Publicado: (2013)

Corrigendum: Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination
por: Kratochvil, Sven, et al.
Publicado: (2018)

Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery
por: Nasiri, Muhammad Iqbal, et al.
Publicado: (2021)

Enhanced Intradermal Delivery of Nanosuspensions of Antifilariasis Drugs Using Dissolving Microneedles: A Proof of Concept Study
por: Permana, Andi Dian, et al.
Publicado: (2019)

Microneedle-Facilitated Intradermal Proretinal Nanoparticle Delivery
por: Limcharoen, Benchaphorn, et al.
Publicado: (2020)

Hydrogel-Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery
por: Donnelly, Ryan F, et al.
Publicado: (2012)

Transferrin conjugation confers mucosal molecular targeting to a model HIV-1 trimeric gp140 vaccine antigen()
por: Mann, J.F.S., et al.
Publicado: (2012)

Microneedle‐based intradermal delivery of stabilized dengue virus
por: Turvey, Michelle E., et al.
Publicado: (2019)

Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge
por: Liu, Ying, et al.
Publicado: (2018)

Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: Potential for enhanced treatment of psoriasis
por: Tekko, Ismaiel A., et al.
Publicado: (2020)

Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice
por: Buffa, Viviana, et al.
Publicado: (2012)

Author Correction: Intradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge
por: Liu, Ying, et al.
Publicado: (2023)

Design and characterisation of a dissolving microneedle patch for intradermal vaccination with heat-inactivated bacteria: A proof of concept study
por: Rodgers, Aoife M., et al.
Publicado: (2018)

Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery
por: Tu, Jing, et al.
Publicado: (2017)

P11-09. Mucosal vaccination with a transferrin-gp140 conjugate via the nasal but not vaginal route elicits robust systemic and vaginal IgG and IgA responses
por: Mann, JF, et al.
Publicado: (2009)

Fluid absorption by skin tissue during intradermal injections through hollow microneedles
por: Shrestha, Pranav, et al.
Publicado: (2018)

Intradermal Glycine Detection with a Wearable Microneedle Biosensor: The First In Vivo Assay
por: Wang, Qianyu, et al.
Publicado: (2022)

Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting
por: Spearman, P, et al.
Publicado: (2012)

Frequent Anti-V1V2 Responses Induced by HIV-DNA Followed by HIV-MVA with or without CN54rgp140/GLA-AF in Healthy African Volunteers
por: Msafiri, Frank, et al.
Publicado: (2020)

P11-06. Intravaginal administration of HIV-1ZM96 gp140 augments systemic and mucosal antibody responses following systemic priming with adjuvanted protein
por: Cranage, M, et al.
Publicado: (2009)

Enhancing Intradermal Delivery of Lidocaine by Dissolving Microneedles: Comparison between Hyaluronic Acid and Poly(Vinyl Pyrrolidone) Backbone Polymers
por: Ramadon, Delly, et al.
Publicado: (2023)

Thymic stromal lymphopoietin (TSLP) acts as a potent mucosal adjuvant for HIV-1 gp140 vaccination in mice
por: Van Roey, Griet A, et al.
Publicado: (2012)

Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles
por: Pan, Jingtong, et al.
Publicado: (2018)

AMOUNT AND DURATION OF IMMUNITY INDUCED BY INTRADERMAL INOCULATION OF CULTURED VACCINE VIRUS
por: Rivers, Thomas M., et al.
Publicado: (1939)

Cannot write session to /tmp/vufind_sessions/sess_vevu2l4nvep2boif2j052bcock